The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice
Study Type
OBSERVATIONAL
Enrollment
2,006
Hallym University Sacred Heart Hospital
Anyang, South Korea
Composite event rate
Death, non fatal myocardial infarction, Target Vessel Revascularization
Time frame: 1year
All death
Time frame: 5year
Cardiac death
Time frame: 5year
Myocardial infarction
Time frame: 5year
Composite event of death or myocardial infarction
Time frame: 5year
Composite event of cardiac death or myocardial infarction
Time frame: 5year
Target Vessel revascularization
Time frame: 5year
Target lesion revascularization
Time frame: 5year
Stent thrombosis by an Academic Research Consortium (ARC) criteria
Time frame: 5year
Stroke
Time frame: 5year
Procedural success
defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization participants will be followed for the duration of hospital stay, an expected average of 3days.
Time frame: 3day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Chungbuk National University Hospital
Cheongju-si, South Korea
Gangwon National Univ. Hospital
Chuncheon, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Yeungnam University Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
...and 15 more locations